首页 | 本学科首页   官方微博 | 高级检索  
     


Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes
Affiliation:1. AdventHealth Translational Research Institute, 301 East Princeton Street, Orlando, FL 32804, USA;2. AdventHealth Diabetes Institute, 2415 North Orange Avenue, Suite 501, Orlando, FL 32804, USA;1. Metamor Institute, Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA;2. Integrative Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Louisiana State University, 6400 Perkins Road, Baton Rouge, LA 70808, USA;1. Division of Endocrinology and Metabolism, Brigham and Women''s Hospital, Harvard Medical School, 221 Longwood Avenue, BLI 541, Boston, MA 02115, USA;2. Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA;3. Northwestern Medicine McHenry Hospital, Chicago Medical School, Rosalind Franklin University of Medicine and Science, McHenry, IL, USA;1. Department of Pediatrics, Boston Children Hospital, Harvard Medical School, Boston, MA, USA;2. University of Alabama at Birmingham, 1601, 4th Avenue South, CPP M 30, Birmingham, AL 35233, USA;1. Royal North Shore Hospital, Level 4, Acute Services Building, St Leonards, Sydney, NSW 2065, Australia;2. Gastroenterology and Hepatology, Bankstown-Lidcombe Hospital, Eldridge Road, Bankstown, NSW 2200, Australia;3. University of Sydney, Sydney, Australia;4. Gastroenterology and Hepatology, Westmead Hospital, Westmead, Australia
Abstract:
Keywords:Type 2 diabetes  Older adults  DPP-4 inhibitors  GLP-1 receptor agonists  SGLT-2 inhibitors  Tirzepatide  Diabetes subtypes  Precision medicine
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号